Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Long-Term Debt Repayments (2022 - 2023)

Korro Bio (KRRO) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $11.7 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Long-Term Debt Repayments changed N/A year-over-year to $11.7 million, compared with a TTM value of $15.0 million through Sep 2023, changed N/A, and an annual FY2022 reading of $833000.0, changed N/A over the prior year.
  • Long-Term Debt Repayments was $11.7 million for Q2 2023 at Korro Bio, up from $2.5 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $11.7 million in Q2 2023 and bottomed at $833000.0 in Q4 2022.